Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.7M Buy
53,336
+11,882
+29% +$729K 0.01% 1027
2026
Q1
$2.71M Sell
41,454
-12
-0% -$878 0.02% 933
2025
Q4
$3.34M Buy
41,466
+20,460
+97% +$1.64M 0.06% 355
2025
Q3
$1.72M Buy
21,006
+6,683
+47% +$579K 0.02% 986
2025
Q2
$1.31M Sell
14,323
-1,656
-10% -$148K 0.01% 994
2025
Q1
$1.46M Buy
15,979
+1,709
+12% +$149K 0.02% 870
2024
Q4
$1.21M Buy
14,270
+1,165
+9% +$102K 0.02% 920
2024
Q3
$1.15M Buy
13,105
+2,510
+24% +$211K 0.02% 864
2024
Q2
$836K Buy
+10,595
New +$871K 0.01% 909

Other funds holding DOX

Empowered Funds's DOX Position: Q2 2026 in Review

Empowered Funds increased its Amdocs (DOX) stake by 29% in Q2 2026, buying an estimated $729K and bringing the position to 53,336 shares worth $2.7M. The position accounts for 0.01% of the portfolio, ranked #1027.

Empowered Funds first reported a position in DOX in Q2 2024 and has held it in 9 quarters since. The position peaked at $3.34M in Q4 2025. 447 funds tracked by Wall St. Rank hold DOX as of Q2 2026.

  • Empowered Funds held 53,336 shares of Amdocs worth $2.7M as of Q2 2026.
  • Empowered Funds bought 11,882 Amdocs shares in Q2 2026, an estimated $729K.
  • Amdocs made up 0.01% of Empowered Funds's portfolio in Q2 2026, its #1027 holding.
  • Empowered Funds first reported a position in Amdocs in Q2 2024 and has held it in 9 quarters since.
  • Empowered Funds's Amdocs position peaked at $3.34M in Q4 2025.
  • 447 funds tracked by Wall St. Rank held Amdocs as of Q2 2026.

Based on Empowered Funds's 13F filing for Q2 2026, filed 17 Aug 2026.